LUND, Sweden, Feb. 21, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that the company has entered into an exclusive agreement to license and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results